Loading…

The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial

Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients 2021-04, Vol.13 (5), p.1417
Main Authors: Kimble, Rachel, Keane, Karen M, Lodge, John K, Howatson, Glyn
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63
cites cdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63
container_end_page
container_issue 5
container_start_page 1417
container_title Nutrients
container_volume 13
creator Kimble, Rachel
Keane, Karen M
Lodge, John K
Howatson, Glyn
description Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period. Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m ) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months. No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention ( > 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults.
doi_str_mv 10.3390/nu13051417
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_449ddcd4428044cba0b1062c56401e01</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A765866800</galeid><doaj_id>oai_doaj_org_article_449ddcd4428044cba0b1062c56401e01</doaj_id><sourcerecordid>A765866800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</originalsourceid><addsrcrecordid>eNptks1u1DAQxyMEolXphQdAlrgAaoq_4iQckFYrCiu1oirL2XLsya4Xx17spFIfkPfC7Za2K2Ef7LF_8_fMeIriNcGnjLX4o58IwxXhpH5WHFJc01IIzp4_2R8Uxylt8O2ocS3Yy-Ige1LKW3ZY_FmuAS187ybwGlDo0VLFEc3XEOMNeocu4-SnhDRElaZ0gvQ1ugh-HELM_M17NA_ZzY9RjYB-TNutgyGbarTBoz5ExO7wdULZnqtobBhgVF1wVqMrm36hM6XHEBOyHl1YYxyUsxUYNDOTG9MnNENXypsw2ATmBF06paELZX51jMG5DC6jVe5V8aJXLsHx_XpU_Dz7spx_K8-_f13MZ-elrlg7lh1Rne4IEEJwzWjV0BaY6KqamIZQqBnoVpsWGgU95kowTlpTGaZaAcC0YEfFYqdrgtrIbbSDijcyKCvvDkJcyVw9qx1IzltjtOGcNphz3SncESyorgTHBDDJWp93WtupG8Dsquj2RPdvvF3LVbiWDeFV_sYs8PZeIIbfE6RRbsIUfc5f0opRUlctJ4_USuWorO9DFtO5nlrOalE1QjQYZ-r0P1SeBgarg4fe5vM9hw87Bx1DShH6h8AJlreNKR8bM8Nvnqb6gP5rQ_YXx8feaQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532175941</pqid></control><display><type>article</type><title>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Kimble, Rachel ; Keane, Karen M ; Lodge, John K ; Howatson, Glyn</creator><creatorcontrib>Kimble, Rachel ; Keane, Karen M ; Lodge, John K ; Howatson, Glyn</creatorcontrib><description>Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period. Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m ) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months. No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention ( &gt; 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu13051417</identifier><identifier>PMID: 33922493</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adults ; Anthocyanins ; Anti-inflammatory agents ; Antioxidants ; Blood pressure ; C-reactive protein ; cardiovascular disease ; Cherries ; Clinical trials ; Diabetes ; Dietary supplements ; Disease ; Exercise ; Fruits ; Health risks ; Heart beat ; Heart rate ; Hormone replacement therapy ; Hypertension ; Inflammation ; Insulin ; Lipids ; metabolic health ; Metabolism ; Metabolites ; Middle age ; Mortality ; Nitric oxide ; Physical fitness ; Placebos ; Prunus cerasus ; Questionnaires ; Risk analysis ; Risk factors ; tart cherry ; Type 2 diabetes ; vascular function ; Wave velocity</subject><ispartof>Nutrients, 2021-04, Vol.13 (5), p.1417</ispartof><rights>COPYRIGHT 2021 MDPI AG</rights><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</citedby><cites>FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</cites><orcidid>0000-0001-8494-2043 ; 0000-0002-1572-9211</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2532175941/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2532175941?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33922493$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kimble, Rachel</creatorcontrib><creatorcontrib>Keane, Karen M</creatorcontrib><creatorcontrib>Lodge, John K</creatorcontrib><creatorcontrib>Howatson, Glyn</creatorcontrib><title>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</title><title>Nutrients</title><addtitle>Nutrients</addtitle><description>Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period. Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m ) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months. No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention ( &gt; 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults.</description><subject>Adults</subject><subject>Anthocyanins</subject><subject>Anti-inflammatory agents</subject><subject>Antioxidants</subject><subject>Blood pressure</subject><subject>C-reactive protein</subject><subject>cardiovascular disease</subject><subject>Cherries</subject><subject>Clinical trials</subject><subject>Diabetes</subject><subject>Dietary supplements</subject><subject>Disease</subject><subject>Exercise</subject><subject>Fruits</subject><subject>Health risks</subject><subject>Heart beat</subject><subject>Heart rate</subject><subject>Hormone replacement therapy</subject><subject>Hypertension</subject><subject>Inflammation</subject><subject>Insulin</subject><subject>Lipids</subject><subject>metabolic health</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Middle age</subject><subject>Mortality</subject><subject>Nitric oxide</subject><subject>Physical fitness</subject><subject>Placebos</subject><subject>Prunus cerasus</subject><subject>Questionnaires</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>tart cherry</subject><subject>Type 2 diabetes</subject><subject>vascular function</subject><subject>Wave velocity</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks1u1DAQxyMEolXphQdAlrgAaoq_4iQckFYrCiu1oirL2XLsya4Xx17spFIfkPfC7Za2K2Ef7LF_8_fMeIriNcGnjLX4o58IwxXhpH5WHFJc01IIzp4_2R8Uxylt8O2ocS3Yy-Ige1LKW3ZY_FmuAS187ybwGlDo0VLFEc3XEOMNeocu4-SnhDRElaZ0gvQ1ugh-HELM_M17NA_ZzY9RjYB-TNutgyGbarTBoz5ExO7wdULZnqtobBhgVF1wVqMrm36hM6XHEBOyHl1YYxyUsxUYNDOTG9MnNENXypsw2ATmBF06paELZX51jMG5DC6jVe5V8aJXLsHx_XpU_Dz7spx_K8-_f13MZ-elrlg7lh1Rne4IEEJwzWjV0BaY6KqamIZQqBnoVpsWGgU95kowTlpTGaZaAcC0YEfFYqdrgtrIbbSDijcyKCvvDkJcyVw9qx1IzltjtOGcNphz3SncESyorgTHBDDJWp93WtupG8Dsquj2RPdvvF3LVbiWDeFV_sYs8PZeIIbfE6RRbsIUfc5f0opRUlctJ4_USuWorO9DFtO5nlrOalE1QjQYZ-r0P1SeBgarg4fe5vM9hw87Bx1DShH6h8AJlreNKR8bM8Nvnqb6gP5rQ_YXx8feaQ</recordid><startdate>20210423</startdate><enddate>20210423</enddate><creator>Kimble, Rachel</creator><creator>Keane, Karen M</creator><creator>Lodge, John K</creator><creator>Howatson, Glyn</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8494-2043</orcidid><orcidid>https://orcid.org/0000-0002-1572-9211</orcidid></search><sort><creationdate>20210423</creationdate><title>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</title><author>Kimble, Rachel ; Keane, Karen M ; Lodge, John K ; Howatson, Glyn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adults</topic><topic>Anthocyanins</topic><topic>Anti-inflammatory agents</topic><topic>Antioxidants</topic><topic>Blood pressure</topic><topic>C-reactive protein</topic><topic>cardiovascular disease</topic><topic>Cherries</topic><topic>Clinical trials</topic><topic>Diabetes</topic><topic>Dietary supplements</topic><topic>Disease</topic><topic>Exercise</topic><topic>Fruits</topic><topic>Health risks</topic><topic>Heart beat</topic><topic>Heart rate</topic><topic>Hormone replacement therapy</topic><topic>Hypertension</topic><topic>Inflammation</topic><topic>Insulin</topic><topic>Lipids</topic><topic>metabolic health</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Middle age</topic><topic>Mortality</topic><topic>Nitric oxide</topic><topic>Physical fitness</topic><topic>Placebos</topic><topic>Prunus cerasus</topic><topic>Questionnaires</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>tart cherry</topic><topic>Type 2 diabetes</topic><topic>vascular function</topic><topic>Wave velocity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimble, Rachel</creatorcontrib><creatorcontrib>Keane, Karen M</creatorcontrib><creatorcontrib>Lodge, John K</creatorcontrib><creatorcontrib>Howatson, Glyn</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimble, Rachel</au><au>Keane, Karen M</au><au>Lodge, John K</au><au>Howatson, Glyn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial</atitle><jtitle>Nutrients</jtitle><addtitle>Nutrients</addtitle><date>2021-04-23</date><risdate>2021</risdate><volume>13</volume><issue>5</issue><spage>1417</spage><pages>1417-</pages><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>Tart Montmorency cherries (MC) have been shown to be rich in anthocyanins and other phytochemicals known to have anti-inflammatory properties and influence pathways that might improve cardiometabolic health. However, there is limited evidence for the longer-term use of tart cherries on these indices. The aim of the current study was to investigate the influence of MC concentrate on cardiometabolic health indices following a 3-month supplementation period. Fifty middle-aged adults (34 males and 16 females; mean ± SD age: 48 ± 6 years and BMI: 27.6 ± 3.7 kg/m ) completed a randomised, placebo-controlled parallel study in which they either received MC or an isocaloric placebo. Participants drank 30 mL of their allocated treatment twice per day for 3 months. Vascular function (blood pressure [BP], heart rate [HR], pulse wave velocity and analysis [PWV/A], and flow mediated dilation [FMD]) as well as indices of metabolic health (insulin, glucose, lipid profiles, and high sensitivity C reactive protein) were measured following an overnight fast before and after the 3 months. No effect of the intervention between the groups was observed for vascular function or metabolic health variables following the intervention ( &gt; 0.05). However, MC concentrate was shown to be safe and well-tolerated and, importantly, did not have any deleterious effects on these outcomes. In conclusion, MC has no influence on cardiometabolic indices in middle-aged adults.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33922493</pmid><doi>10.3390/nu13051417</doi><orcidid>https://orcid.org/0000-0001-8494-2043</orcidid><orcidid>https://orcid.org/0000-0002-1572-9211</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6643
ispartof Nutrients, 2021-04, Vol.13 (5), p.1417
issn 2072-6643
2072-6643
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_449ddcd4428044cba0b1062c56401e01
source Publicly Available Content Database; PubMed Central
subjects Adults
Anthocyanins
Anti-inflammatory agents
Antioxidants
Blood pressure
C-reactive protein
cardiovascular disease
Cherries
Clinical trials
Diabetes
Dietary supplements
Disease
Exercise
Fruits
Health risks
Heart beat
Heart rate
Hormone replacement therapy
Hypertension
Inflammation
Insulin
Lipids
metabolic health
Metabolism
Metabolites
Middle age
Mortality
Nitric oxide
Physical fitness
Placebos
Prunus cerasus
Questionnaires
Risk analysis
Risk factors
tart cherry
Type 2 diabetes
vascular function
Wave velocity
title The Influence of Tart Cherry ( Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A40%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Influence%20of%20Tart%20Cherry%20(%20Prunus%20cerasus,%20cv%20Montmorency)%20Concentrate%20Supplementation%20for%203%20Months%20on%20Cardiometabolic%20Risk%20Factors%20in%20Middle-Aged%20Adults:%20A%20Randomised,%20Placebo-Controlled%20Trial&rft.jtitle=Nutrients&rft.au=Kimble,%20Rachel&rft.date=2021-04-23&rft.volume=13&rft.issue=5&rft.spage=1417&rft.pages=1417-&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu13051417&rft_dat=%3Cgale_doaj_%3EA765866800%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c539t-b1abcb1e11107325829e36b571d812e73ec9cd9e8aef04a63419d5d3a96ee3c63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2532175941&rft_id=info:pmid/33922493&rft_galeid=A765866800&rfr_iscdi=true